Royalty Pharma PLC expected to post earnings of 99 cents a share - Earnings Preview

Royalty Pharma

06/08/2024 19:55

* Royalty Pharma PLC  RPRX.OQ   RPRX.O  is expected to show
a rise
in quarterly revenue when it reports  results on August 8 for
the period ending June 30 2024
    * The New York City-based  company is expected to report a
16.8% increase in revenue to $628.265 million from $538 million
a year ago, according to the mean estimate from 4 analysts,
based on LSEG data.
    * ​LSEG's mean analyst estimate for Royalty Pharma PLC is
for
earnings of 99 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Royalty
Pharma
PLC is $46.00​, above​ its last closing price of $27.46. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Mar. 31 2024  0.96        0.98       0.98      Met     -0.2
 Dec. 31 2024  1.05        1.01       1.15      Beat    13.9
 Jan. 1 0001   0.77        0.76       0.79      Beat    4.5​
 Jun. 30 2023  0.81        0.81       0.84      Beat    4
 ​​Mar.        1.30        1.27       1.60      Beat    25.7
 31 2023                                                
 Dec. 31 2022  1.39        1.47       1.56      Beat    5.9​
 Sep. 30 2022  0.71        0.72       0.72      Met     0.5
 Jun. 30 2022  0.79        0.78       0.79      Beat    1.1
 This summary was machine generated August 6 at 18:55 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)